Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMPZS7U)

Drug Name
Oxyphenbutazone Drug Info
Synonyms Tandearil
Indication
Disease Entry ICD 11 Status REF
Arthritis FA20 Approved [1]
Cross-matching ID
PubChem CID
4641
ChEBI ID
CHEBI:76258
CAS Number
CAS 129-20-4
TTD Drug ID
DMPZS7U

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Serum albumin (ALB) TTFNGC9 ALBU_HUMAN Modulator [2]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Serum albumin (ALB) DTT ALB 7.535 2.536 4.755 4.7
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Arthritis
ICD Disease Classification FA20
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Serum albumin (ALB) DTT ALB 7.92E-01 -0.07 -0.44
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin. J Pharm Sci. 1982 Feb;71(2):241-4.